Priming a vascular-selective cytokine response permits cd8+ t-cell entry into tumors

HIGHLIGHTS

• who: Dae Joong Kim from the All animal experiments were carried out in accordance with and under the approval of the Institutional Animal Care and use Committee (IACUC) of the University of Virginia (accredited by AAALAC International) and followed the Public Health Service Policy for the Care and Use of Laboratory AnimalsAnimal care was provided in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals, and protocols were approved by IACUC (Protocol #4146). The maximum tumor size of , cm, was permitted by IACUC. In some cases, this limit has been . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.